In the competitive medical device industry, what must companies do to avoid being left behind by their competitors?
In our sector of the industry, pharmaceutical companies select their suppliers very carefully often through track record and a history of successful products. The medical device industry constantly seeks ways to improve its offering; for example, Cambridge Consultants has a good track record in the industry, but is constantly searching for ways to pre-empt market needs and target innovation opportunities. Cambridge Consultants’s Gen-X platform. Q8: Cambridge Consultants has utilized the specification to bring a number of DPIs to market, including the Gen-X platform that was launched in 2008. Can you tell us more about this inhaler? The Gen-X is a reference design for a generic DPI, delivering 60 doses of a lactose-based formulation for the treatment of asthma/chronic obstructive pulmonary disease. It is aimed at generic drug products where drug delivery performance needs to match currently marketed products. Gen-X is designed to be low cost with fewer parts while simultaneously matchin
